Table 3.
Species | Factors Involved | Neurotransmitter Identity | Regional Patterning | Other Validations | Reference |
---|---|---|---|---|---|
Mouse | Brn2, Ascl1, Mytl1 | Majority glutamatergic; many GABAergic; undetectable dopaminergic, cholinergic or serotinergic | Majority cortical | Immunostaining, electrophysiology | Vierbuchen et al.32 |
Human | BRN2, ASCL1, MYTL1, NEUROD1 | Majority glutamatergic; few GABAergic; few dopaminergic; undetectable cholinergic or serotinergic | 17% Forebrain; undetectable midbrain; 21% PNS | Immunostaining, qPCR, electrophysiology | Pang et al.33 |
Human | miR-124, MYTL1, BRN2 | 44% glutamatergic; 8% GABAergic; rare dopaminergic; undetectable cholinergic or serotinergic | Central nervous system | Immunostaining, electrophysiology | Ambasudhan et al.34 |
Human | miR-124, miR-9/9, NEUROD2, ASCL1, MYT1L | Mixture of glutamatergic and GABAergic; few serotonergic; undetectable dopaminergic | Majority cortical; few striatum or cerebellum; undetectable PNS | Immunostaining, qPCR, electrophysiology, stimulation-dependent calcium imaging, exit from cell cycle (EdU) | Yoo et al.35 |
Mouse, human | MASH1, ASCL1, NURR1, LMX1A | 85% dopaminergic; undetectable adrenergic or serotonergic | Midbrain | Immunostaining, qPCR, gene expression profiling, electrophysiology, dopaminergic release (HPLC), transplantation | Caiazzo36 |
Mouse | Ascl1, Pitx3, (Lmx1a, Nurr1, Foxa2, EN1) | Midbrain dopaminergic neurons | Midbrain | Immunostaining, qPCR, gene expression profiling, dopaminergic release (HPLC), transplantation | Kim et al.37 |
Note: GABA, gamma-aminobutyric acid; HPLC, high-performance liquid chromatography; PNS, peripheral nervous system; qPCR, quantitative PCR.